Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -1.59%19 Current Ratio is 16.88 as of Jun. 2026, which is 11% above its 10-year median of 15.25. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Medeze Group PCL ranks better than 98.69% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medeze Group PCL's current ratio for the quarter that ended in Jun. 2026 was 16.88.
Medeze Group PCL has a current ratio of 16.88. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Medeze Group PCL's Current Ratio or its related term are showing as below:
BKK:MEDEZE'
s Current Ratio Range Over the Past 10 Years
Min: 1.87 Med: 15.25 Max: 17.8
Current: 16.88
During the past 3 years, Medeze Group PCL's highest Current Ratio was 17.80. The lowest was 1.87. And the median was 15.25.
BKK:MEDEZE's Current Ratio is ranked better than 98.69% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.435
vs BKK:MEDEZE: 16.88
Medeze Group PCL (BKK:MEDEZE) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medeze Group PCL Current Ratio Related Terms
Medeze Group PCL Current Ratio Historical Data
* Premium members only.
The historical data trend for Medeze Group PCL's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MEDEZE vs HCA, THC, EHC: Current Ratio Comparison
For the Medical Care Facilities subindustry, Medeze Group PCL's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a Current Ratio of 16.88 as of Jun. 2026. This is 11% above median its historical median of 15.25. Over the past decade, Medeze Group PCL's Current Ratio has ranged from 1.87 to 17.80. According to the industry distribution chart, Medeze Group PCL ranks #9 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 1.3%.
Is Medeze Group PCL's Current Ratio too high?
Medeze Group PCL's current Current Ratio of 16.88 is 11% above median its 10-year median of 15.25. Over the past 10 years, this metric has ranged from a low of 1.87 to a high of 17.80. The Healthcare Providers & Services industry median Current Ratio is 1.44. Medeze Group PCL's value of 16.88 is 1076.3% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #9 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #9 out of 686 companies for Current Ratio. This places Medeze Group PCL in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.44. Medeze Group PCL's value of 16.88 is 1076.3% above this benchmark. Historically, Medeze Group PCL's own Current Ratio has ranged from 1.87 to 17.80 over the past decade. While the company's 10-year median is 15.25 vs. the industry median of 1.44, Medeze Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.44, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current Current Ratio of 16.88 is 1076.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current Current Ratio is 16.88, which is 11% above median its own 10-year median of 15.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current Current Ratio of 16.88. The current Current Ratio is 16.88, which is 11% above median its 10-year median of 15.25 and 1076.3% above the Healthcare Providers & Services industry median of 1.44. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current Current Ratio is 16.88 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
